Skip to main content
Clinical Trials/NCT00584363
NCT00584363
Completed
Not Applicable

Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection (UAB/UMN SPORE in Pancreatic Cancer)

University of Alabama at Birmingham1 site in 1 country731 target enrollmentJune 2004

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pancreatic Cancer
Sponsor
University of Alabama at Birmingham
Enrollment
731
Locations
1
Primary Endpoint
To diagnose Pancreatic Cancer
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of the study is to collect pancreatic tissue, blood and urine from adults to study pancreatic abnormalities.

Detailed Description

The aim of the study is to standardize, collect and share pancreatic cancer related information, to be used for research purposes only by researchers from different participating institutions/centers.

Registry
clinicaltrials.gov
Start Date
June 2004
End Date
September 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Charles Mel Wilcox, MD

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • Person over 19 years of age, patient with a tissue-proven diagnosis of pancreatic cancer at the University of Alabama at Birmingham (UAB) University Hospital during the period, and cognitive ability to provide informed consent

Exclusion Criteria

  • Person not 19 or older and have not had a tissue-proven diagnosis of pancreatic cancer.

Outcomes

Primary Outcomes

To diagnose Pancreatic Cancer

Time Frame: 5 years

Secondary Outcomes

  • Preventing patient form being misdiagnosed(5 years)

Study Sites (1)

Loading locations...

Similar Trials